For example, different ZipFv can be used to regulate the function of CD4+ T cells (to help secrete cytokines) and CD8+ T cells (to kill cancer cells directly), thus improving the release of some anti‐tumor cytokines, which help CAR‐T cells to achieve better anti‐tumor outcomes [93, 95]. Here, CD8A is linked to neoplasm.